Published January 11, 2022 | Version v1
Dataset Open

Virtual screening of 2629 Janssen compounds against SARS-CoV-2 RdRP

  • 1. Janssen Pharmaceutica NV


This short report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 RdRP and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.


Files (147.0 kB)